1 / 62

Spring 2008

Spring 2008. Case-Control Studies and Odds Ratio STAT 6395. Filardo and Ng. Types of Epidemiologic studies. Case-Control studies.

adonica
Download Presentation

Spring 2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Spring 2008 Case-Control Studies and Odds Ratio STAT 6395 Filardo and Ng

  2. Types of Epidemiologic studies

  3. Case-Control studies A study in which a group of persons with a disease (cases) and a comparison group of persons without the disease (controls) are compared with respect to the history of past exposures to factors of interest

  4. Case-Control studies A study in which a group of persons with a disease (cases) and a comparison group of persons without the disease (controls) are compared with respect to the history of past exposures to factors of interest Past Time Present Type of studies Observational Case-Control

  5. Case-Control studies (study schema) Type of studies Observational Case-Control

  6. Cohort studies A study in which a group of persons exposed to a factor of interest and a group of persons not exposed are followed and compared with respect to the incidence rate of the disease or other condition of interest Time Type of studies Observational Cohort studies

  7. Comparison is fundamental in determining the relationship between an exposure and a disease • Cohort study • Incidence rate in exposed group is not enough (Needs nonexposed comparison group) • Case-control study • Past exposures of a group of cases is not enough (Needs a control group for comparison)

  8. Fundamental difference between a case-control study and a cohort study • A case-control study starts with people: a) with; and b) without the disease of interest and compares their past exposures • A cohort study starts with people: a) with; and b) without the exposure of interest and compares their future disease

  9. Time

  10. The fundamental difference between a case-control study and a cohort study is not the calendar time period during which exposures took place …for example, in a both a retrospective cohort study and a case-control study, the calendar time period during which exposures took place is in the past

  11. How do we measure past exposures in a case-control study? • Interview • Medical records/charts • Assays of biological specimens (e.g. nested case-control studies) Goal is to measure exposures that occurred before the onset of disease

  12. Selection of cases: incident vs. prevalent • Incident (newly diagnosed) cases • Risk factors might contribute to the development of the disease • Prevalent (existing) cases • Cannot distinguish between risk factors for the development of the disease and risk factors for cure or survival • More difficult to know which came first, the exposure or the disease • Exposure measurements problematic Prevalence = Number of a given disease at a particular time point or during a particular time period (this is a proportion and not a rate)

  13. Selection of cases • Definition of source population -- the population that gives rise to the cases • Case definition -- need to have definite medical criteria for who is a case of the disease • Case identification -- need to put a system in place for finding all cases who meet the case definition and are members of the source population Source Population Cases and Controls

  14. Selection of controls • Selection of appropriate controls is the major methodological challenge in case-control studies • In a case-control study, we want to determine whether exposures of interest differ between the case group and the source population • Controls should be selected from the source population that gave rise to the cases. Source Population Cases and Controls

  15. Selection of controls (continued) • The controls should be representative of the source population with respect to the exposures of interest. • Ideally, controls should be a random sample of the source population. Prevalent cases of the disease should not be eligible to be controls

  16. Study I: Controls selected such that they have a higher level of exposure than the source population, producing an an artifactual result that the exposure is negatively associated with the disease

  17. Study II: Controls selected such that they have a lower level of exposure than the source population, producing an artifactual result that the exposure is positively associated with the disease

  18. Study III: Controls selected such that they have the same level of exposure as the source population, producing the unbiased (true) result that the exposure is not associated with the disease

  19. Case-control studies classified by type of source population (population that gives rise to the cases) • Population-based case-control studies • Hospital (or clinic)-based case-control studies • Nested case-control studies Case-Control studies Population-based, hospital-based, nested

  20. Population-based case-control studies • Source population: all residents of a defined geographic area who do not have Disease X • Cases: all new cases of Disease X that occur among residents of a defined geographic area over a specified period of time • Controls: sample (ideally random) of the source population over the same period of time Case-Control studies Population-based, hospital-based, nested

  21. Population-based: Parkinson’s disease • Source population: residents of Texas who do not have Parkinson’s disease • Cases: all new cases of Parkinson’s disease among Texas residents identified over a 3 year period through a rapid-reporting system • Controls: sample (ideally random) of residents of Texas who do not develop Parkinson’s disease over the same 3 year period Case-Control studies Population-based, hospital-based, nested

  22. Selection of controls in population-based case-control studies • Random sample from a population registry • Neighborhood controls -- sample of persons who reside in the same neighborhoods as the cases • Often done by matching Case-Control studies Population-based, hospital-based, nested

  23. Selection of controls in population-based case-control studies (continued) • Random selection of telephone numbers (random digit dialing) members of the source population does not have the same probability of being contacted (not a random sample): • persons without a landline have zero probability of being selected • households vary the amount of time someone is home and number of telephones • many people screen their telephone calls Case-Control studies Population-based, hospital-based, nested

  24. Hospital-based case-control studies • Source population: all people without Disease X who would attend Hospital A if they had Disease X • Cases: all new cases of Disease X identified in Hospital A over a specified period of time • Controls (most commonly): sample of patients in Hospital A with diagnoses other than Disease X over the same period of time Case-Control studies Population-based, hospital-based, nested

  25. Hospital-based: Parkinson’s disease • Source population: all persons who would attend Baylor University Medical Center (BUMC) if they had Parkinson’s disease • Note that this source population is, in practice, impossible to identify • Cases: all new cases of Parkinson’s disease seen at BUMC over a 3 year period • Controls: sample of patients at BUMC with diagnoses other than Parkinson’s disease over the same 3 year period Case-Control studies Population-based, hospital-based, nested

  26. Selection of controls in hospital-based case-control studies • Source population: all persons who would attend the hospital if they developed the disease of interest • Source population in a hospital-based case-control study is usually not identifiable • A random sample of the general population will not necessarily correspond to a random sample of the source population because it does not take into account the referral patterns of the hospital • Furthermore, referral pattern depends on the disease Case-Control studies Population-based, hospital-based, nested

  27. Selection of controls in hospital-based case-control studies (continued) • Hospital-based controls are patients without the disease from the same hospital • Hospital-based controls are a nonrandom sample of the source population, most of whom are healthy • Nonrandom sampling of the source population introduces the possibility that the distribution of the exposure of interest among the controls is not the same as it is in the source population Case-Control studies Population-based, hospital-based, nested

  28. Hospital-based controls may not reflect the exposure distribution in the source population • Exposures of interest may cause or prevent the diseases for which patients in the control group were hospitalized Case-Control studies Population-based, hospital-based, nested

  29. Hospital-based controls may not reflect the exposure distribution in the source population • Persons with an exposure of interest may be more or less likely than persons without the exposure to be hospitalized for their disease if they develop it (this could also be an issue for cases) Case-Control studies Population-based, hospital-based, nested

  30. Hospital-based controls unrepresentative of the exposure distribution in the source population: Parkinson’s disease • Controls: random sample of persons hospitalized for other diseases, many of whom were hospitalized for heart disease • Low folic acid intake is a risk factor for heart disease • This control group would have a lower proportion of persons with high folic acid intake than the source population Case-Control studies Population-based, hospital-based, nested

  31. Controls selected such that they have a lower level of exposure than the source population, producing an artifactual result that the exposure is positively associated with the disease Case-Control studies Population-based, hospital-based, nested

  32. Selection of controls in hospital-based case-control studies (continued) • Limit the controls to those hospitalized for diseases for which there is no suspicion of a relationship with the exposures of interest Case-Control studies Population-based, hospital-based, nested

  33. Selection of controls in hospital-based case-control studies (continued) • Include a variety of diseases in the control group, so as to dilute the biasing effects of including a disease that might related to the exposure, unbeknownst to the investigator Case-Control studies Population-based, hospital-based, nested

  34. Selection of controls in hospital-based case-control studies (continued) • Excluded diseases should only apply to the diagnosis at the current hospitalization Case-Control studies Population-based, hospital-based, nested

  35. Excluded diseases should only apply to the diagnosis at the current hospitalization: Parkinson’s disease • Controls: persons hospitalized due to traumatic injury, who are believed to be representative of the source population with respect to folic acid intake • Persons with a history heart disease should not be excluded from this traumatic injury control group. This would cause the control group to have an over-representation of persons with high folic acid intake Case-Control studies Population-based, hospital-based, nested

  36. Controls selected such that they have ahigher level of exposure than the source population, producing an an artifactual result that the exposure is negatively associated with the disease Case-Control studies Population-based, hospital-based, nested

  37. Nested case-control studies (nested within a concurrent cohort study) • Source population: the subjects in an ongoing concurrent cohort study who did not have Disease X at baseline • Cases: all new cases of Disease X that occurred in the cohort over a defined period of follow-up • Controls: random sample of subjects in the cohort who did not develop Disease X over the defined period of follow-up Case-Control studies Population-based, hospital-based, nested

  38. Nested case-control studies (nested within a concurrent cohort study) • Exposures measured by assay of stored biologic specimens collected from the subjects at baseline Nested case-control study has advantage of cohort studies: exposure measured at baseline before development of disease

  39. Nested case-control studies (nested within a concurrent cohort study) • Collection of additional exposure information not collected at baseline requires labor-intensive data collection activities, such as abstraction from records Nested case-control study has advantage of cohort studies: exposure measured at baseline before development of disease

  40. Nested case-control studies (nested within a concurrent cohort study) biologic specimens collected from the subjects at baseline cases and controls identified specimens used to assess exposure and compare it among study groups Time Case-Control studies Population-based, hospital-based, nested

  41. Nested case-control: Parkinson’s disease • Source population: the members of the Nurses’ Health Study cohort who donated blood samples in 1989-1990 and had no history of Parkinson’s disease • Cases: all new cases of Parkinson’s disease that developed in this source population from 1991 to 2000 • Controls: random sample of the Nurses’ Health Study cohort who did not develop Parkinson’s disease from 1991 to 2000 • Measurement of exposure: serum folic acid level at baseline Case-Control studies Population-based, hospital-based, nested

  42. Advantages of the nested case-control studies over the concurrent cohort study itself • Cost: suppose there were 32,000 women in the source population, 200 cases, and 200 controls. • Causality: the exposure occurred before the disease • Further research: preservation of precious biologic specimens –remaining specimens available for other studies Case-Control studies Population-based, hospital-based, nested

  43. Accounting for confounders in selecting controls Matching -- selection of controls such that they are similar to cases with respect to factors other than the exposures of interest

  44. Matching • Common matching factors: age, sex, race, socioeconomic status Accounting for confounders Matching

  45. Matching • Frequency matching: selection of controls such that the distributions of the matching factors (e.g., age, sex) are similar in the case and control groups Accounting for confounders Matching

  46. Matching • Individual matching: each control is individually matched to a case with respect to specific factors, resulting in matched case-control pairs • For example, for each case, select a control of the same race, sex, age (within 3 years), neighborhood (within 3 blocks) Accounting for confounders Matching

  47. Matching is intuitively appealing, but its implications are complicated … • In a case-control study, the association between matching factors and disease cannot be studied Accounting for confounders Matching

  48. Matching is intuitively appealing, but its implications are complicated … • Overmatching can occur if a matching factor is associated with the exposure of interest, thus making the controls artifactually like the cases with respect to that exposure Accounting for confounders Matching

  49. Matching is intuitively appealing, but its implications are complicated … • Matching must be taken into account in the analysis through special analytic techniques • We will cover some of these techniques in this course Accounting for confounders Matching

  50. Conventional data layout for case-control study (2x2 table)

More Related